GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Spectral AI Inc (NAS:MDAI) » Definitions » EV-to-EBIT

Spectral AI (Spectral AI) EV-to-EBIT : -2.62 (As of Jun. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Spectral AI EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Spectral AI's Enterprise Value is $24.23 Mil. Spectral AI's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-9.24 Mil. Therefore, Spectral AI's EV-to-EBIT for today is -2.62.

The historical rank and industry rank for Spectral AI's EV-to-EBIT or its related term are showing as below:

MDAI' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.62   Med: -2.94   Max: -1.81
Current: -2.62

During the past 3 years, the highest EV-to-EBIT of Spectral AI was -1.81. The lowest was -9.62. And the median was -2.94.

MDAI's EV-to-EBIT is ranked worse than
100% of 450 companies
in the Medical Devices & Instruments industry
Industry Median: 19.075 vs MDAI: -2.62

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Spectral AI's Enterprise Value for the quarter that ended in Mar. 2024 was $33.49 Mil. Spectral AI's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-9.24 Mil. Spectral AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -27.58%.


Spectral AI EV-to-EBIT Historical Data

The historical data trend for Spectral AI's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral AI EV-to-EBIT Chart

Spectral AI Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBIT
- - -2.82

Spectral AI Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial - - -3.92 -2.82 -3.63

Competitive Comparison of Spectral AI's EV-to-EBIT

For the Medical Devices subindustry, Spectral AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral AI's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Spectral AI's EV-to-EBIT falls into.



Spectral AI EV-to-EBIT Calculation

Spectral AI's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=24.227/-9.238
=-2.62

Spectral AI's current Enterprise Value is $24.23 Mil.
Spectral AI's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral AI  (NAS:MDAI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Spectral AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-9.238/33.492299
=-27.58 %

Spectral AI's Enterprise Value for the quarter that ended in Mar. 2024 was $33.49 Mil.
Spectral AI's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral AI EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Spectral AI's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral AI (Spectral AI) Business Description

Traded in Other Exchanges
N/A
Address
2515 McKinney Avenue, Suite 1000, Dallas, TX, USA, 75201
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely and informed decision regarding the treatment of the patient's wound.
Executives
John Michael Dimaio 10 percent owner 6125 LUTHER LANE, DALLAS TX 75225
Michael Patrick Murphy director 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153
Els 1960 Family, L.p. 10 percent owner 2323 VICTORY AVE., SUITE. 700, DALLAS TX 75219
Richard John Cotton director RUE DU VILLAGE 4, CHAMPERY V8 1874
Mellish Martin C.b. director 13 BERRILL FARMS LN, HANOVER NH 03755
Jeffrey Edward Thatcher officer: Chief Scientist 6659 ESCONDIDO ST, IRVING TX 75039
Nils Windler officer: Chief Financial Officer 8602 NAPA LANDING, SAN ANTONIO TX 78015
Wensheng Fan director, officer: CHIEF EXECUTIVE OFFICER 3320 SPRING MOUNTAIN DRIVE, PLANO TX 75025
Vincent S. Capone officer: GENERAL COUNSEL 1620 GRASSHOPPER LANE, LOWER GWYNEDD PA 19002
Nikolaos Pagoulatos officer: CHIEF OPERATING OFFICER 5122 IROQUOIS DR, FRISCO TX 75034
Xiaojia Cynthia Cai director 10 CELESTIAL WAY, NEWARK DE 19711
Heather Bellini director 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153
Edmonds Franklin S. Jr. director 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153
Rosecliff Acquisition Sponsor I Llc director 767 FIFTH AVENUE, 34TH FLOOR, NEW YORK NY 10153
Erich Spangenberg 10 percent owner 73 595 EL PASEO, SUITE 2204, PALM DESERT CA 92260